Navigation Links
PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
Date:7/10/2012

mmercial products, including any long-acting versions of human growth hormone, erythropoietin, interferon beta, GLP-1 and other products; that the long-acting products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; that the actual dollar amount of any grants from Israel's Office of the Chief Scientist is uncertain and is subject to policy changes of the Israeli government, and that such grants may be insufficient to assist with product development; and other risks and uncertainties that may cause results to differ materially from those set forth in the forward-looking statements. The results of clinical trials in humans may produce results that differ significantly from the results of clinical and other trials in animals. The results of early-stage trials may differ significantly from the results of more developed, later-stage trials. The development of any products using the CTP platform technology could also be affected by a number of other factors, including unexpected safety, efficacy or manufacturing issues, additional time requirements for data analyses and decision making, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing and the impact of patents and other proprietary rights held by competitors and other third parties.  In addition to the risk factors described above, investors should consider the economic, competitive, governmental, technological and other factors discussed in PROLOR's filings with the Securities and Exchange Commission.  The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements, except as required u
'/>"/>
SOURCE PROLOR Biotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Data From Phase II Trial of Prolor Biotechs Long-acting Human Growth Hormone Presented at Endo 2012
2. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
3. Puma Biotechnology Announces Completion of Private Placement
4. Animal Biotechnology - Technologies, Markets and Companies
5. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
6. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
7. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
8. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
9. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
10. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
11. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... CA (PRWEB) July 30, 2014 Adding ... their weighing boat special – Buy 2 ... free. This promotion will benefit lab technicians looking for ... Weighing boats are ideal for multiple applications including weighing ... a variety of choices including diamond-shaped, hexagonal, square, aluminum ...
(Date:7/29/2014)... Boston, MA (PRWEB) July 30, 2014 ... communication (UC) and collaboration company, is proud to ... and account management positions in their Boston, Charleston ... in response to the increased demand for hosted ... enhance operational efficiency and reduce cost. , SoundConnect ...
(Date:7/29/2014)... The advanced optical methods and applications ... driving a revolution in the neurosciences were the inspiration ... by SPIE, the international society for optics and ... launch of the BRAIN Initiative in the United States, ... a vision for and provide examples of the impact ...
(Date:7/29/2014)... Quantum Cheshire Cat: Can a particle be separated from ... Nature Communications , published the results of the first ... field, conducted by Chapman University in Orange, CA, and ... seen a cat without a grin," thought Alice in ... most curious thing I ever saw in my life!" ...
Breaking Biology Technology:Weighing Boat Promotion Now Available at Pipette.com, Major Pipette Distributor 2SoundConnect Organization and Culture is Evolving 2SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 2SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 3SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 4The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4
... Kingchem to Act as Agent to Find Partner ... for North American MarketsLAS VEGAS, April 3 ... Board: SNBP) ("Sinobiopharma") (the "Company") is pleased to ... export agreement with Kingchem, an international marketing organization ...
... ChromaDex Corporation, (OTC Bulletin Board: CDXC) a ... today announced financial results for the 2008 Fiscal ... with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ... stockholders of $0.07 per share for the twelve ...
... April 3 Savient Pharmaceuticals, Inc. (Nasdaq: ... definitive agreements with select existing and new institutional investors ... share of its common stock, $0.01 par value per ... of its common stock in a registered direct offering ...
Cached Biology Technology:Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier 2ChromaDex Announces 2008 Year End Financial Results 2ChromaDex Announces 2008 Year End Financial Results 3Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering 2Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering 3Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering 4
(Date:7/28/2014)... professor John Essigmann and colleagues from the University of Washington ... if they could induce the virus to mutate uncontrollably, they ... a strategy that our immune system uses against many viruses. ... HIV to mutate at an enhanced rate, as expected. But ... small clinical trial reported in 2011. In a new study, ...
(Date:7/28/2014)... of Solanum pennellii , a wild relative of ... group of researchers including the labs headed by Professors ... Department of Plant Biology. The new genome information may ... work, published July 27 in the journal Nature ... at Aachen University in Germany. The UC Davis labs ...
(Date:7/28/2014)... new study suggest two ways to effectively address the problem ... obese women, compared to women of a normal body mass ... say, but as the population has increased in weight, concern ... women. Studies have consistently found that obesity has a negative ... turn affect how well the pill prevents pregnancy. ...
Breaking Biology News(10 mins):Forced mutations doom HIV 2Forced mutations doom HIV 3Forced mutations doom HIV 4Strategies identified to improve oral contraceptive success with obese women 2
... synchrotron-based imaging techniques to identify previously unseen anatomy preserved in ... old lizard skin identified the presence of teeth (invisible to ... animal was more than just a skin moult. This was ... universe, x-rays generated by a synchrotron. Dr Phil ...
... , This press release is available in ... researcher at the Centre for Studies on Human Stress (CSHS) ... de Montral suggests that bullying by peers changes the structure ... vulnerable to mental health problems as they age. The ...
... As the federal government builds on its $1 billion investment ... research consortium has developed innovative new maps of both environmental ... remediation of the world,s largest fresh water resource. Writing ... the National Academy of Science ( PNAS ), a ...
Cached Biology News:Prehistoric ghosts revealing new details 2Bullying by childhood peers leaves a trace that can change the expression of a gene linked to mood 2Mapping effort charts restoration tack for Great Lakes 2Mapping effort charts restoration tack for Great Lakes 3